Meeting
2023 ASCO Annual Meeting
Association between real-world, upfront, next-generation sequencing and overall survival (OS) in advanced non–small-cell lung cancer (aNSCLC) in the United States.
Authors
Benjamin Philip Levy
John Hopkins Sidney Kimmel Cancer Center, Washington, DC
Benjamin Philip Levy , Danny Nguyen , Yu-Hsuan Shih , Magdaliz Gorritz , Beilei Cai , Nydia Caro , Marie Yasuda , Yifan Gu , Chi-Chang Chen , Vincent Pretre , Teddy Rassem Saliba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9117)
DOI
10.1200/JCO.2023.41.16_suppl.9117
Abstract #
9117
Poster Bd #
105
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Clinical and economic outcomes associated with upfront comprehensive genomic profiling in newly diagnosed advanced lung cancer in the United States from 2018-2020: Evidence from the SEQUENCE study.
First Author: Gboyega Adeboyeje
Poster
2020 ASCO Virtual Scientific Program
Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study.
First Author: Adam Gondos
Poster
2019 ASCO Annual Meeting
Genomic testing and treatment landscape in patients with advanced non-small cell lung cancer (aNSCLC) using real-world data from community oncology practices.
First Author: Hinco Jasper Gierman
Poster
2024 ASCO Annual Meeting
Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09).
First Author: Heejung Chae